A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of Zampilimab in Healthy Participants

Clinical trial NCT04705350 · COMPLETED

Trial details

NCT number: NCT04705350
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Study Participants

Start date: 2021-01-11
Primary completion: 2021-07-28
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.